PDCD1 and cancer: The TTE cells become terminally differentiated, late dysfunctional TCF1lo/- PD-1+ TIM3+ T cells (TLD) that carry distinct transcriptional and epigenetic programs that differ from those seen in traditional memory and effector populations, both in cancer and chronic viral infection (Figures 1, 2; Table 1) (8, 19, 22).